Diabetes Home > Bydureon Alternatives
Other Incretin Mimetics
Bydureon is an incretin mimetic. The three other incretin mimetics currently available are exenatide (Byetta®), iraglutide (Victoza®), and dulaglutide (Trulicity™). Exenatide is a short-acting version of Bydureon.
These medications work by acting like the hormone incretin in the body, increasing insulin production and slowing down digestion. One of the most notable differences among the incretin mimetics is that Bydureon and Trulicity are injected once a week, Victoza is usually injected once a day, and Byetta is typically injected twice a day.
There is one amylin analogue available called pramlintide (Symlin®). This medication works like the hormone amylin in the body, increasing insulin production, slowing digestion, decreasing the production of glucose by the liver, and reducing appetite.
Insulin is available in rapid-, short-, long-, or intermediate-acting forms.
Oral Diabetes MedicinesMany different types of oral medications are available to treat type 2 diabetes, including:
- Alpha glucosidase inhibitors
- Dipeptidyl peptidase inhibitors
- Ergot alkaloids
- Sodium-glucose co-transporter 2 inhibitors (SGLT2 inhibitors)
- Bile acid sequestrants
- Combination medications.
Sulfonylureas are medications that force the pancreas to make more insulin. As a result, they are effective at controlling blood sugar, but are also more likely to cause dangerously low blood sugar (hypoglycemia). These medications include: